For eco-conscious consumers of personal medical devices, recycling options are limited. Some companies are trying to change that.
Category: Drugs (Pharmaceuticals)
-
Can You Recycle Medical Devices Like Insulin Pens, Inhalers and Covid Tests?
Inhalers, EpiPens, home tests for flu or Covid, mouth guards. They accumulate in our homes, and recycling methods and advice can be tricky to pin down.
-
Severe Frostbite Gets a Treatment That May Prevent Amputation
The F.D.A. recently approved the first therapy for patients in danger of losing their toes, fingers and other exposed parts of the body.
-
NY AG Urges Stricter Asthma Drug Warnings Due to Children’s Mental Health Risks
The A.G., Letitia James, called on the F.D.A. to redouble efforts to alert doctors about potential side effects of Singulair and to consider discouraging use of the drug in children.
-
US Agencies Start Inquiry Into Generic Drug Shortages
The F.T.C. and H.H.S. are examining the tactics of group purchasing organizations that generic industry executives say have led to scarce supplies of treatments like chemotherapy.
-
Journal Retracts Studies Cited in Federal Court Ruling Against Abortion Pill
The journal found that the studies, which had suggested that medication abortion is unsafe, included incorrect factual assumptions and misleading presentation of the data.
-
J&J, Merck and Bristol Myers Squibb CEOs Will Testify at Senate Hearing on Drug Prices
The top executives of three major companies are set to appear on Thursday before a Senate panel led by Mr. Sanders, who has made lowering drug costs a signature issue.
-
Medicare Recipients Can Save on Drugs in 2024
Federal law set caps on some spending for seniors who are enrolled in Part D prescription drug plans. Those paying for high-cost medicines will benefit.
-
6 Reasons That It’s Hard to Get Your Wegovy and Other Weight-Loss Prescriptions
An array of obstacles make it difficult for patients to obtain Wegovy or Zepbound. Finding Wegovy is “like winning the lottery,” one nurse practitioner said.
-
U.S. Makes Initial Offers in Medicare Drug Price Negotiations
The offers amount to a starting gun in the price talks between the federal government and the makers of 10 prescription drugs that have been selected for negotiations.
-
Biogen Abandons Its Controversial Alzheimer’s Drug Aduhelm
The pharmaceutical company will give up its ownership rights to the drug and stop a clinical trial that had been aimed at confirming whether it works.
-
Buried in Wegovy Costs, North Carolina Will Stop Paying for Obesity Drugs
Starting April 1, state employees in North Carolina will no longer have insurance coverage for costly weight-loss medications like Wegovy and Zepbound.